Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Prevalence of metabolic associated fatty liver disease (MAFLD) in patients with gallstone disease. Study on a cohort of cases in South-Southeastern Mexico
F. Roesch-Dietlen; A.G. Pérez-Morales; P. Grube-Pagola; M. González-Santes; F. Díaz-Roesch; A. Triana-Romero; L. Roesch-Ramos; J.M. Remes-Troche; M. Cruz-Aguilar;
Rev Gastroenterol Mex. 2023;88:225-31
Latin American consensus on the quality indicators for comprehensive care clinics for patients with inflammatory bowel disease: PANCCO-GETECCU
J.K. Yamamoto-Furusho; D. Andrade; J. Barahona; S. Bautista; F. Bosques-Padilla; J. de Paula; M.T. Galiano; B. Iade; F. Juliao-Baños; G. Otoya; F. Steinwurz; E. Torres; G. Veitia; M. Barreiro-de Acosta;
Rev Gastroenterol Mex. 2022;87:89-102
Inflammatory bowel disease in Mexico: Epidemiology, burden of disease, and treatment trends
J.K. Yamamoto-Furusho; F.J. Bosques-Padilla; L. Charúa-Guindic; T. Cortés-Espinosa; R.M. Miranda-Cordero; A. Saez; Y. Ledesma-Osorio;
Rev Gastroenterol Mex. 2020;85:246-56